Volpara (ASX:VHT) share price falls on half-year results

The Volpara Health Technologies Ltd (ASX: VHT) share price is falling today after the company announced its half-yearly results for FY21.
The post Volpara (ASX:VHT) share price falls on half-year results appeared first on Motley Fool Australia. –

falling healthcare asx share represented by doctor with head in hands

The Volpara Health Technologies Ltd (ASX: VHT) share price is falling today after the company announced its half-yearly results for FY21. At the time of writing, the Volpara share price is down 2.8% to $1.39.

Let’s take a closer look to see what’s moving the Volpara share price today.

What’s driving the Volpara share price lower?

It seems, despite reporting a decent result for its FY21 half-year performance, the company’s performance has failed to meet investors’ expectations, if the falling Volpara share price is anything to go by. 

For the period ending 30 September, Volpara received total revenue of NZ$9.5 million, up 38% on the prior corresponding period (pcp). This was underpinned by a 71% increase in its subscription revenue of NZ$8.8 million.

Annual recurring revenue (ARR) grew to NZ$19.9 million compared to the NZ$15.7 million recorded at the half-year of FY20.

Average revenue per user (ARPU) also lifted to US$1.16, up 26% over the comparable period.

Net operating cash outflow came to NZ$7.8 million, a slight improvement from the NZ$7.9 million that was recorded in the first half of FY20. COVID-19 brought some challenges to the business, affecting sales and marketing techniques which involved face-to-face contact and trade shows. As a result, the company decided to move further into the digital marketing space, and is starting to see results.

Overall, the group stood at a net loss of NZ$8.9 million, however this is an 11% upturn on the pcp.

The company revealed a holding cash balance of NZ$64.3 million at the end of the period. The jump from its NZ$31.4 million achieved at the end of FY20 was due to a recent capital raising of NZ$29.5 million.

Furthermore, the cash balance includes a NZ$2.6 million low-interest loan received as a COVID-19 relief package from the United States government.

Management commentary

Volpara CEO, Dr Ralph Highnam, commented on the group’s achievement for the first-half of the year. He said:

In the face of this unprecedented challenge, we proactively modified our strategic approach on several fronts. We shifted to digital marketing, reshaped our US commercial team, and began investigating ways to address women directly to drive demand. We are focusing on R&D to generate improved products and services. And we have developed a new sales model to lower the cost of customer acquisitions.

Fortunately, we have a healthy balance sheet, and with vaccines seemingly on the horizon, the environment should correct itself in due course.

FY21 outlook

Looking towards the remaining part of the FY21, Volpara advised that it is on track to meet its expectations for the full-year. No guidance amount was given in the report however.

ARR is anticipated to grow in the coming months, but may be at a slower rate as COVID-19 is affecting its US market.

ARPU is also expected to rise despite the chance of the company losing contracts with a number of clinics. This is due to Volpara targeting MRS System customers to upgrade to its software-as-a-service (SaaS) platform. SaaS is viewed by Volpara as being much more meaningful to revenue than ARPU.

Volpara share price summary

The Volpara share price has lost ground over the past six months, falling by 6%. In comparison, the All Ordinaries Index (ASX: XAO) has moved more than 20% higher over the same time frame.

Whether or not the Volpara share price can reach its former glory when it was trading around the $2 mark remains to be seen. It will be interesting to watch the company’s developments before reporting its full year-result in May next year.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Volpara (ASX:VHT) share price falls on half-year results appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!